Local, concomitant administration of tolerogenic synthetic nanocarriers to reduce type I and type IV hypersensitivity
- 专利权人:
- Selecta Biosciences; Inc.
- 发明人:
- Maldonado, Roberto A.
- 申请号：
- AU2014262162
- 公开号：
- AU2014262162B2
- 申请日:
- 2014.05.02
- 申请国别(地区):
- AU
- 年份:
- 2019
- 代理人:
- 摘要：
- Disclosed are methods and related compositions for administering immunosuppressants and therapeutic macromolecules for enhancing CD4+ regulatory T cells.
- 来源网站：
- 中国工程科技知识中心
相关发明人
相关专利
- LOCAL, CONCOMITANT ADMINISTRATION OF TOLEROGENIC SYNTHETIC NANOCARRIERS TO REDUCE TYPE I AND TYPE IV HYPERSENSITIVITY
- LOCAL ACCOMPANYING INTRODUCTION OF TOLEROGENOUS SYNTHETIC NANOSATORS TO REDUCE HYPERSENSITIVITY TYPE I AND HYPERSENSITIVITY TYPE IV
- METHODS PROVIDING A THERAPEUTIC MACROMOLECULE AND SYNTHETIC NANOCARRIERS COMPRISING IMMUNOSUPPRESSANT LOCALLY AND CONCOMITANTLY TO REDUCE BOTH TYPE 1 AND TYPE IV HYPERSENSITIVITY
- Methods providing a therapeutic macromolecule and synthetic nanocarriers comprising immunosuppressant locally and concomitantly to reduce both type I and type IV hypersensitivity
- METHOD FOR PREDICTING INDIVIDUAL HYPERSENSITIVITY OF IMMEDIATE TYPE IN ANIMALS FOLLOWING ADMINISTRATION OF IMMUNOTROPIC AGENTS
